Abou-Issa H - Search Results

1

Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronide.

Alshafie GA, Walker JR, Curley RW Jr, Clagett-Dame M, Highland MA, Nieves NJ, Stonerock LA, Abou-Issa H. Alshafie GA, et al. Among authors: abou issa h. Anticancer Res. 2005 May-Jun;25(3c):2391-8. Anticancer Res. 2005. PMID: 16082771 Free article.

2

An improved synthesis of the C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.

Walker JR, Alshafie G, Abou-Issa H, Curley RW Jr. Walker JR, et al. Among authors: abou issa h. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2447-50. doi: 10.1016/s0960-894x(02)00427-4. Bioorg Med Chem Lett. 2002. PMID: 12161154

3

Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.

Walker JR, Alshafie G, Nieves N, Ahrens J, Clagett-Dame M, Abou-Issa H, Curley RW Jr. Walker JR, et al. Among authors: abou issa h. Bioorg Med Chem. 2006 May 1;14(9):3038-48. doi: 10.1016/j.bmc.2005.12.044. Epub 2006 Jan 10. Bioorg Med Chem. 2006. PMID: 16412653 Free PMC article.

4

Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.

Abou-Issa HM, Alshafie GA, Curley RW Jr, Wong MF, Clagett-Dame M, Repa JJ, Sikri V. Abou-Issa HM, et al. Anticancer Res. 1999 Mar-Apr;19(2A):999-1004. Anticancer Res. 1999. PMID: 10368645

5

Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.

Alshafie GA, Abou-Issa HM, Seibert K, Harris RE. Alshafie GA, et al. Among authors: abou issa hm. Oncol Rep. 2000 Nov-Dec;7(6):1377-81. doi: 10.3892/or.7.6.1377. Oncol Rep. 2000. PMID: 11032948

6

Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.

Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL, Harris RE. Abou-Issa HM, et al. Anticancer Res. 2001 Sep-Oct;21(5):3425-32. Anticancer Res. 2001. PMID: 11848504

7

Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis.

Abou-Issa H, Moeschberger M, el-Masry W, Tejwani S, Curley RW Jr, Webb TE. Abou-Issa H, et al. Anticancer Res. 1995 May-Jun;15(3):805-10. Anticancer Res. 1995. PMID: 7645962

8

In vivo use of N-(4-hydroxyphenyl retinamide)-0-glucuronide as a breast cancer chemopreventive agent.

Abou-Issa H, Curley RW Jr, Panigot MJ, Wilcox KA, Webb TE. Abou-Issa H, et al. Anticancer Res. 1993 Sep-Oct;13(5A):1431-6. Anticancer Res. 1993. PMID: 8239515

9

Basis for the anti-tumor and chemopreventive activities of glucarate and the glucarate:retinoid combination.

Abou-Issa H, Dwivedi C, Curley RW Jr, Kirkpatrick R, Koolemans-Beynen A, Engineer FN, Humphries KA, el-Masry W, Webb TE. Abou-Issa H, et al. Anticancer Res. 1993 Mar-Apr;13(2):395-9. Anticancer Res. 1993. PMID: 8517653

10

Chemopreventive activities of C-glucuronide/glycoside analogs of retinoid-O-glucuronides against breast cancer development and growth.

Curley RW Jr, Abou-Issa H, Panigot MJ, Repa JJ, Clagett-Dame M, Alshafie G. Curley RW Jr, et al. Anticancer Res. 1996 Mar-Apr;16(2):757-63. Anticancer Res. 1996. PMID: 8687125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters